Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.36 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | EDNRA | P25101 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1892190 | 0.91 | PPARG (0.46) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL4011296 | 0.90 | PPARG (0.47) | PPARGACHETNIKAGTR1AGTR2 | |
| SCHEMBL4010058 | 0.85 | PPARG (0.50) | PPARGACHETNIKAGTR1AGTR2 | |
| SCHEMBL4011246 | 0.84 | PPARG (0.49) | PPARGACHEAGTR1AGTR2EDNRA | |
| SCHEMBL4011269 | 0.83 | PPARG (0.46) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL1892572 | 0.81 | PPARG (0.47) | PPARGACHEAGTR1 | |
| SCHEMBL4016998 | 0.81 | PPARG (0.45) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL1899839 | 0.79 | PPARG (0.47) | PPARGACHEAGTR1 | |
| SCHEMBL4012027 | 0.79 | PPARG (0.63) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL1889008 | 0.78 | AGTR1 (0.54) | PPARGAGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009133970-A1 | CRYSTALLINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-05 | — | — | WO | disclosed |
| EP-2074117-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008062905-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-29 | — | — | WO | disclosed |